Glaukos (GKOS) News Today $100.86 -0.38 (-0.38%) Closing price 03/20/2025 03:59 PM EasternExtended Trading$101.70 +0.84 (+0.83%) As of 03/20/2025 06:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Glaukos Co. (NYSE:GKOS) Shares Bought by Intech Investment Management LLCIntech Investment Management LLC grew its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 44.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,601 shares of the medical inMarch 20 at 5:25 AM | marketbeat.comSwiss National Bank Has $16.21 Million Holdings in Glaukos Co. (NYSE:GKOS)Swiss National Bank increased its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 9.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 108,100 shares of the medical instruments supplier's stock after buying anMarch 19 at 4:06 AM | marketbeat.comWilliam Blair Investment Management LLC Takes Position in Glaukos Co. (NYSE:GKOS)William Blair Investment Management LLC acquired a new position in Glaukos Co. (NYSE:GKOS - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 809,589 shares of the medical instruments suppMarch 18 at 6:57 AM | marketbeat.comGlaukos Co. (NYSE:GKOS) Shares Sold by Primecap Management Co. CAPrimecap Management Co. CA reduced its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 2.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,214,325 shares of the medical instruments supplier's stock after seMarch 18 at 6:02 AM | marketbeat.comRaymond James Financial Inc. Purchases New Position in Glaukos Co. (NYSE:GKOS)Raymond James Financial Inc. purchased a new stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 112,771 shares of the medical instruments supplier's stock, valued at approMarch 18 at 3:30 AM | marketbeat.comGlaukos Co. (NYSE:GKOS) Shares Acquired by Zurcher Kantonalbank Zurich CantonalbankZurcher Kantonalbank Zurich Cantonalbank increased its stake in Glaukos Co. (NYSE:GKOS - Free Report) by 36.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,939 shares of the mediMarch 17, 2025 | marketbeat.comWhat is Zacks Research's Forecast for Glaukos Q4 Earnings?March 17, 2025 | americanbankingnews.comWhat is Zacks Research's Estimate for Glaukos Q4 Earnings?Glaukos Co. (NYSE:GKOS - Free Report) - Zacks Research upped their Q4 2026 earnings estimates for shares of Glaukos in a research note issued on Thursday, March 13th. Zacks Research analyst I. Bandyopadhyay now anticipates that the medical instruments supplier will earn $0.06 per share for the quMarch 17, 2025 | marketbeat.comAmundi Reduces Position in Glaukos Co. (NYSE:GKOS)Amundi decreased its holdings in Glaukos Co. (NYSE:GKOS - Free Report) by 4.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 115,418 shares of the medical instruments supplier's stock after selling 5March 14, 2025 | marketbeat.comVictory Capital Management Inc. Has $11.16 Million Stock Position in Glaukos Co. (NYSE:GKOS)Victory Capital Management Inc. cut its holdings in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 6.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 74,402 shares of the medical inMarch 14, 2025 | marketbeat.comHere's Why You Should Retain Glaukos Stock in Your PortfolioMarch 13, 2025 | msn.comPNC Financial Services Group Inc. Has $5.18 Million Stake in Glaukos Co. (NYSE:GKOS)PNC Financial Services Group Inc. boosted its holdings in Glaukos Co. (NYSE:GKOS - Free Report) by 817.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 34,541 shares of the medical inMarch 13, 2025 | marketbeat.comGlaukos, RadiusXR collaborate with Topcon Healthcare on vision testing platformMarch 11, 2025 | markets.businessinsider.comGlaukos (NYSE:GKOS) Stock Price Down 9.8% - Here's What HappenedGlaukos (NYSE:GKOS) Stock Price Down 9.8% - What's Next?March 11, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 8,936 Shares of Glaukos Co. (NYSE:GKOS)Charles Schwab Investment Management Inc. grew its position in Glaukos Co. (NYSE:GKOS - Free Report) by 1.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 650,697 shares of the medical instruments supplier's stock after buying anMarch 10, 2025 | marketbeat.comGlaukos Co. (NYSE:GKOS) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Glaukos Co. (NYSE:GKOS - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the thirteen ratings firms that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, eleven have assigned aMarch 10, 2025 | marketbeat.comGlaukos Co. (NYSE:GKOS) Stock Position Lifted by Lisanti Capital Growth LLCLisanti Capital Growth LLC grew its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 39.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 29,790 shares of the medical instruments supplier'March 8, 2025 | marketbeat.comBank of New York Mellon Corp Increases Holdings in Glaukos Co. (NYSE:GKOS)Bank of New York Mellon Corp raised its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 3.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 397,842 shares of the medical instruments supplier's stock aMarch 5, 2025 | marketbeat.comIs Glaukos Corporation (GKOS) the Best Medical Technology Stock to Buy According to Analysts?March 5, 2025 | msn.comOppenheimer Asset Management Inc. Lowers Position in Glaukos Co. (NYSE:GKOS)Oppenheimer Asset Management Inc. cut its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 41.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,658 shares of the medical instruments supMarch 4, 2025 | marketbeat.comNew York Life Investment Management LLC Invests $848,000 in Glaukos Co. (NYSE:GKOS)New York Life Investment Management LLC purchased a new position in shares of Glaukos Co. (NYSE:GKOS - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 5,656 shares of the medical instrumenMarch 4, 2025 | marketbeat.comGlaukos (NYSE:GKOS) Shares Down 6.3% - Should You Sell?Glaukos (NYSE:GKOS) Trading Down 6.3% - Time to Sell?March 3, 2025 | marketbeat.com5,789 Shares in Glaukos Co. (NYSE:GKOS) Acquired by Williamson Legacy Group LLCWilliamson Legacy Group LLC purchased a new position in Glaukos Co. (NYSE:GKOS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,789 shares of the medical instruments supplier's stock, vMarch 2, 2025 | marketbeat.comTruist Financial Corp Sells 5,319 Shares of Glaukos Co. (NYSE:GKOS)Truist Financial Corp decreased its position in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 41.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,370 shares of the medical instruments supplier's stockMarch 1, 2025 | marketbeat.comTaylor Frigon Capital Management LLC Decreases Position in Glaukos Co. (NYSE:GKOS)Taylor Frigon Capital Management LLC lowered its stake in Glaukos Co. (NYSE:GKOS - Free Report) by 10.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 25,012 shares of the medical instruments supplier's stock after sellFebruary 27, 2025 | marketbeat.comMorgan Stanley Reaffirms Their Sell Rating on Glaukos (GKOS)February 26, 2025 | markets.businessinsider.comFDA gives Glaukos ‘Day 74’ notice for Epioxa NDA to treat keratoconusFebruary 24, 2025 | markets.businessinsider.comFDA accepts Glaukos application for Epioxa for keratoconusFebruary 24, 2025 | msn.comGlaukos Announces FDA Acceptance of NDA Submission for Epioxa™February 24, 2025 | businesswire.comWe're Not Worried About Glaukos' (NYSE:GKOS) Cash BurnFebruary 23, 2025 | finance.yahoo.comGlaukos (NYSE:GKOS) Shares Gap Down Following Weak EarningsGlaukos (NYSE:GKOS) Shares Gap Down on Disappointing EarningsFebruary 22, 2025 | marketbeat.comWells Fargo & Company Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) StockWells Fargo & Company boosted their price objective on Glaukos from $153.00 to $160.00 and gave the stock an "overweight" rating in a report on Friday.February 22, 2025 | marketbeat.comNeedham & Company LLC Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) StockNeedham & Company LLC raised their price objective on shares of Glaukos from $149.00 to $176.00 and gave the company a "buy" rating in a research note on Friday.February 22, 2025 | marketbeat.comGlaukos price target raised to $176 from $149 at NeedhamFebruary 22, 2025 | markets.businessinsider.comPrincipal Financial Group Inc. Trims Stock Position in Glaukos Co. (NYSE:GKOS)Principal Financial Group Inc. lessened its stake in shares of Glaukos Co. (NYSE:GKOS - Free Report) by 6.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 268,534 shares of the medical instruments supplier's stock after selliFebruary 22, 2025 | marketbeat.comGlaukos price target raised to $160 from $153 at Wells FargoFebruary 22, 2025 | markets.businessinsider.comGlaukos (NYSE:GKOS) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPSGlaukos (NYSE:GKOS - Get Free Report) released its quarterly earnings data on Thursday. The medical instruments supplier reported ($0.40) EPS for the quarter, missing analysts' consensus estimates of ($0.38) by ($0.02). Glaukos had a negative return on equity of 18.99% and a negative net margin of 42.43%.February 21, 2025 | marketbeat.comGlaukos Corporation (GKOS) Q4 2024 Earnings Call TranscriptFebruary 21, 2025 | seekingalpha.comGlaukos down 14% at $135 after Q4 results and guidanceFebruary 21, 2025 | markets.businessinsider.comGlaukos (GKOS) Receives a Buy from BTIGFebruary 21, 2025 | markets.businessinsider.comGlaukos reports Q4 EPS (40c), consensus (39c)February 20, 2025 | markets.businessinsider.comInsider Selling: Glaukos Co. (NYSE:GKOS) Insider Sells 3,416 Shares of StockGlaukos Co. (NYSE:GKOS - Get Free Report) insider Tomas Navratil sold 3,416 shares of the stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $147.14, for a total value of $502,630.24. Following the completion of the sale, the insider now directly owns 72,437 shares of the company's stock, valued at $10,658,380.18. The trade was a 4.50 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.February 20, 2025 | marketbeat.comGlaukos Announces Fourth Quarter and Full Year 2024 Financial ResultsFebruary 20, 2025 | businesswire.comMizuho Upgrades Glaukos (GKOS)February 20, 2025 | msn.comWhat To Expect From Glaukos Corp (GKOS) Q4 2024 EarningsFebruary 20, 2025 | finance.yahoo.comGlaukos (NYSE:GKOS) Upgraded by Mizuho to Outperform RatingMizuho raised shares of Glaukos from a "neutral" rating to an "outperform" rating and raised their target price for the company from $140.00 to $200.00 in a report on Wednesday.February 20, 2025 | marketbeat.comTomas Navratil Sells 3,416 Shares of Glaukos Co. (NYSE:GKOS) StockFebruary 20, 2025 | insidertrades.comGlaukos Co. (NYSE:GKOS) Shares Sold by New York State Common Retirement FundNew York State Common Retirement Fund decreased its holdings in Glaukos Co. (NYSE:GKOS - Free Report) by 3.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 381,288 shares of the medical instruments supFebruary 20, 2025 | marketbeat.comPeregrine Capital Management LLC Lowers Stock Position in Glaukos Co. (NYSE:GKOS)Peregrine Capital Management LLC reduced its position in Glaukos Co. (NYSE:GKOS - Free Report) by 97.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,641 shares of the medical instruments supplier's stock after selling 58,3February 20, 2025 | marketbeat.comMizuho upgrades Glaukos to Outperform on ‘bullish’ iDose checksFebruary 19, 2025 | markets.businessinsider.com Remove Ads Get Glaukos News Delivered to You Automatically Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter. Email Address GKOS Media Mentions By Week GKOS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GKOS News Sentiment▼1.240.62▲Average Medical News Sentiment GKOS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GKOS Articles This Week▼137▲GKOS Articles Average Week Remove Ads Get Glaukos News Delivered to You Automatically Sign up to receive the latest news and ratings for GKOS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ZBH News SOLV News SNN News PEN News STVN News BLCO News INSP News NARI News IRTC News PRCT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:GKOS) was last updated on 3/21/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Glaukos Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Glaukos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
